Concentrix vs Genpact
Concentrix reported revenue of $9.8 billion in fiscal 2025, 1.9 times Genpact's $5.1 billion in fiscal 2025. Concentrix's revenue grew 2.1% in its latest year, and Genpact's grew 6.6%. Concentrix had an operating margin of -9.3%, against 14.8% at Genpact. Free cash flow was $572 million at Concentrix and $735 million at Genpact. Their fiscal years end in different months (November 30 and December 31), so the periods don't line up exactly.
Side by side
| Concentrix | Genpact | |
|---|---|---|
| Latest fiscal year | FY2025, Nov 30, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $9.8B | $5.1B |
| Revenue growth | 2.1% | 6.6% |
| Revenue growth a year, last 5 years | 15.8% | 6.5% |
| Gross margin | 35.0% | 36.0% |
| Operating margin | −9.3% | 14.8% |
| Net margin | −13.0% | 10.9% |
| Free cash flow | $572M | $735M |
| Free cash flow margin | 5.8% | 14.5% |
| Return on capital | −9.3% | 19.4% |
| Net debt to EBITDA | — | 0.4x |
| Dividends and buybacks | $258M | $118M |
| Change in diluted share count | −3.2% | −2.1% |
| Last close | $30.32 | $42.27 |
| P/E at the last close | — | 12.3× |
| Insider trades, last 12 months | bought $155,165, sold $133.5 million | sold $8.1 million |
| Piotroski F-score | 4 of 9 | 7 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ConcentrixGenpact
Operating margin
Percent of revenue
ConcentrixGenpact
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ConcentrixGenpact
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Concentrix and Genpact pages.